Erratum for DOI: 10.31662/jmaj.2018-0005

Peter Karagiannis, Ayaka Nakauchi, and Shinya Yamanaka
Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan

DOI: 10.31662/jmaj.e0001

Advance Publication: October 31, 2018
Published: March 4, 2019

Cite this article as:
Karagiannis P, Nakauchi A, Yamanaka S. Erratum for DOI: 10.31662/jmaj.2018-0005. JMA J. 2019;2(1):101.

Article: Karagiannis P, Nakauchi A, Yamanaka S. Bringing Induced Pluripotent Stem Cell Technology to the Bedside. JMA J. 2018;1(1):6-14.

Correction: Reference 15.

Original: Kikuchi T, Morizane A, Doi D, et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model. Nature. 2017;548(7669):592-6.

Corrected: Morizane A, Kikuchi T, Doi D, et al. MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nat Commun. 2017;8(1):385.